Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Añadir filtros








Intervalo de año
1.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 37(1): 71-79, Jan-Mar/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-741940

RESUMEN

Objective: Schizophrenia is one of the most severe psychiatric disorders, and its current treatment relies on antipsychotic medications with only partial effectiveness. Clozapine is an atypical antipsychotic with a specific profile of action indicated for treatment-resistant schizophrenia. Neuroimaging studies assessing the effects of clozapine could help shed light on the neural underpinnings of the effects of this drug in the brain. The objective of this study was to review the available literature on the structural and functional neuroimaging findings associated with use of clozapine. Method: We conducted a systematic review of the indexed literature using the PubMed, BIREME, and ISI Web of Knowledge search engines and the following keywords: clozapine, neuroimaging, computed tomography, MRI, functional magnetic resonance, PET, SPECT, and DTI. Results: A total of 23 articles were included in the review. In structural studies, the use of clozapine was associated with volume reductions in the basal ganglia, especially the caudate nucleus, where functional neuroimaging studies also found decreased perfusion. In the frontal lobe, clozapine treatment was associated with increased gray matter volume and reduced perfusion. Conclusion: The results of the studies reviewed suggest that the use of clozapine is associated with distinctive structural and functional neuroimaging findings that are not shared with other antipsychotics. .


Asunto(s)
Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Trastornos del Conocimiento/etiología , Potenciales Evocados/fisiología , Esquizofrenia/complicaciones , Psicología del Esquizofrénico , Análisis de Varianza , Electroencefalografía , Pruebas Neuropsicológicas , Solución de Problemas , Tiempo de Reacción/fisiología , Estadística como Asunto
2.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 35(4): 406-415, Oct-Dec. 2013.
Artículo en Inglés | LILACS | ID: lil-697332

RESUMEN

Objective: To present the most relevant findings regarding the Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder. Methods: We used the methodology proposed by the Brazilian Medical Association for the Diretrizes Project. The MEDLINE (PubMed), Scopus, Web of Science, and LILACS online databases were queried for articles published from 1980 to 2012. Searchable questions were structured using the PICO format (acronym for “patient” [or population], “intervention” [or exposure], “comparison” [or control], and “outcome”). Results: We present data on clinical manifestations and implications of panic disorder and its association with depression, drug abuse, dependence and anxiety disorders. In addition, discussions were held on the main psychiatric and clinical differential diagnoses. Conclusions: The guidelines are proposed to serve as a reference for the general practitioner and specialist to assist in and facilitate the diagnosis of panic disorder. .


Asunto(s)
Humanos , Trastornos de Ansiedad/diagnóstico , Trastorno de Pánico/diagnóstico , Trastornos de Ansiedad/psicología , Brasil , Trastorno Depresivo/diagnóstico , Diagnóstico Diferencial , Trastorno de Pánico/psicología , Enfermedad de Parkinson , Trastornos Fóbicos/diagnóstico , Sociedades Médicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA